A股異動 | 華錦股份(000059.SZ)大漲逾8% 攜手沙特阿美 集團煉化項目有望快速推進
格隆匯3月14日丨華錦股份(000059.SZ)高開高走,現漲幅擴大至逾8%,報7.7元創逾一個月新高,總市值123億元。當地時間2022 年3月10日,沙特阿美已做出最終投資決定,其合資公司華錦阿美石油化工公司將參與中國東北地區大型煉油化工一體化聯合裝置的開發。華錦阿美石油化工公司是沙特阿美、北方華錦化工集團公司和盤錦鑫誠工業集團的合資企業,該合資企業將開發原油制化學品聯合裝置。光大證券隨後發佈研報稱,隨着中國東北地區大型煉化一體化項目的繼續推進,公司成長空間逐步打開,未來估值有望得到修復,維持“買入”評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.